Willem Adriaan de Jongh
Founder at ExpreS2ion Biotechnologies ApS
Profile
Willem Adriaan de Jongh is the founder of ExpreS2ion Biotechnologies ApS, founded in 2009, where he holds the title of Chief Scientific Officer.
He was also the founder of Expres2ion Biotech Holding AB, founded in 2010, where he held the title of Chief Scientific Officer until 2020.
Currently, he is the Chief Executive Officer & Director at Adaptvac ApS since 2017.
Dr. de Jongh received his doctorate degree from the Technical University of Denmark in 2006 and his undergraduate and graduate degrees from the University of Stellenbosch.
Willem Adriaan de Jongh active positions
| Companies | Position | Start |
|---|---|---|
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Founder | 01/01/2009 |
| Adaptvac ApS | Chief Executive Officer | 01/01/2017 |
Former positions of Willem Adriaan de Jongh
| Companies | Position | End |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Founder | 01/12/2020 |
Training of Willem Adriaan de Jongh
| University of Stellenbosch | Graduate Degree |
| Technical University of Denmark | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Private companies | 2 |
|---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
| Adaptvac ApS |
- Stock Market
- Insiders
- Willem Adriaan de Jongh
